Clover Health Investments Corp. Cl A (CLOV): Price and Financial Metrics

Clover Health Investments Corp. Cl A (CLOV): $2.53

-0.27 (-9.64%)

POWR Rating

Component Grades














  • Momentum is the dimension where CLOV ranks best; there it ranks ahead of 38.1% of US stocks.
  • CLOV's strongest trending metric is Value; it's been moving up over the last 163 days.
  • CLOV's current lowest rank is in the Stability metric (where it is better than 1.88% of US stocks).

CLOV Stock Summary

  • CLOV's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.07 -- higher than merely 0.62% of US-listed equities with positive expected earnings growth.
  • CLOV's went public 1.75 years ago, making it older than just 3.48% of listed US stocks we're tracking.
  • In terms of twelve month growth in earnings before interest and taxes, Clover Health Investments Corp is reporting a growth rate of -3,405.36%; that's higher than just 0.62% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Clover Health Investments Corp, a group of peers worth examining would be INDO, TLS, NCTY, CRNC, and BTBT.
  • CLOV's SEC filings can be seen here. And to visit Clover Health Investments Corp's official web site, go to

CLOV Valuation Summary

  • In comparison to the median Healthcare stock, CLOV's price/earnings ratio is 119.18% lower, now standing at -7.
  • Over the past 17 months, CLOV's EV/EBIT ratio has gone down 4.6.
  • Over the past 17 months, CLOV's EV/EBIT ratio has gone down 4.6.

Below are key valuation metrics over time for CLOV.

Stock Date P/S P/B P/E EV/EBIT
CLOV 2021-08-31 2.7 11.3 -7.0 -6.6
CLOV 2021-08-30 2.7 11.2 -6.9 -6.5
CLOV 2021-08-27 2.7 11.4 -7.0 -6.6
CLOV 2021-08-26 2.7 11.2 -6.9 -6.5
CLOV 2021-08-25 2.8 11.5 -7.1 -6.7
CLOV 2021-08-24 2.8 11.8 -7.3 -6.9

CLOV's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CLOV has a Quality Grade of C, ranking ahead of 33.49% of graded US stocks.
  • CLOV's asset turnover comes in at 1.618 -- ranking 5th of 133 Insurance stocks.
  • 500 - Internal server error

The table below shows CLOV's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.618 0.009 -0.991
2021-03-31 1.251 0.098 -0.276
2020-12-31 1.398 0.148 -0.223
2020-09-30 1.222 0.222 0.038
2020-09-30 0.000 NA -0.006

CLOV Price Target

For more insight on analysts targets of CLOV, see our CLOV price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $9.00 Average Broker Recommendation 2.3 (Moderate Sell)

CLOV Stock Price Chart Interactive Chart >

Price chart for CLOV

CLOV Price/Volume Stats

Current price $2.53 52-week high $28.85
Prev. close $2.80 52-week low $2.51
Day low $2.51 Volume 20,246,100
Day high $2.85 Avg. volume 13,715,336
50-day MA $4.44 Dividend yield N/A
200-day MA $7.83 Market Cap 1.20B

Clover Health Investments Corp. Cl A (CLOV) Company Bio

Clover Health Investments, Corp. provides health insurance services. The company was founded in 2012 and is based in Franklin, Tennessee.

CLOV Latest News Stream

Event/Time News Detail
Loading, please wait...

CLOV Latest Social Stream

Loading social stream, please wait...

View Full CLOV Social Stream

Latest CLOV News From Around the Web

Below are the latest news stories about Clover Health Investments Corp that investors may wish to consider to help them evaluate CLOV as an investment opportunity.

Clover Health Stock Investors Will Need to Buy Into Tech Chief’s Vision

CTO Andrew Toy's innovations like Clover Assistant, seen by some as savior of CLOV stock, are already being adopted by larger Medicare Advantage players.

Dana Blankenhorn on InvestorPlace | January 18, 2022

Clover Health Desperately Needs Triage, but It Isn’t Doomed Yet

Clover Health has a billion dollar yearly book of sales.

Nicolas Chahine on InvestorPlace | January 14, 2022

Polestar Looks Like the Right EV Stock At the Wrong Time

Polestar has a lot of what I look for in a growth stock.

Joanna Makris on InvestorPlace | January 13, 2022

Health insurance costs are growing for America's middle class

Yahoo Finance reporter Adriana Belmonte explains why health insurance deductibles and premiums are eating up a larger share of U.S. households' incomes.

Yahoo | January 12, 2022

COVID: How insurers may be expected to cover testing costs

Chris Meekins, Raymond James Healthcare Policy Analyst, joins Yahoo Finance Live to discuss how private insurers are approaching COVID-19 test costs and the Biden administration's testing plan amid the spread of the Omicron variant. 

Yahoo | January 11, 2022

Read More 'CLOV' Stories Here

CLOV Price Returns

1-mo -39.76%
3-mo -66.27%
6-mo -69.15%
1-year -81.33%
3-year N/A
5-year N/A
YTD -31.99%
2021 -77.82%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8185 seconds.